Cannabis and symptoms of PMS and PMDD

References

• American Psychiatric Association (APA). 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, D.C.: Author.
   Google Scholar
• Bambico FR, Gobbi G. 2008. The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opin Therapeutic Targets. 12:1347–1366.
   PubMed Web of Science ®Google Scholar
• Beraha EM, Cousijn J, Hermanides E, Goudriaan AE, Wiers RW. 2013. Implicit associations and explicit expectancies toward cannabis in heavy cannabis users and controls. Front Psychiatry. [Internet]. 4:1–9. Available from: https://doi.org/10.3389/fpsyt.2013.00059
   PubMedGoogle Scholar
• Bhatia SC, Bhatia SK. 2002. Diagnosis and treatment of premenstrual dysphoric disorder. Am Fam Physician. 66:1239–1249.
   PubMed Web of Science ®Google Scholar
• Bloch M, Schmidt PJ, Rubinow D. 1997. Premenstrual syndrome: evidence for symptom stability across cycles. Am J Psychiatry. 154:1741–1746.
   PubMed Web of Science ®Google Scholar
• Camí J, Guerra D, Ugena B, Segura J, De La Torre R. 1991. Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes. Pharmacol Biochem Behav. 40:115–119.
   PubMed Web of Science ®Google Scholar
• Cunningham J, Yonkers KA, O’Brien S, Eriksson E. 2009. Update on research and treatment of premenstrual dysphoric disorder. Harvard Rev Psychiatry. 17:120–137.
   PubMed Web of Science ®Google Scholar
• Earleywine M. 2005. Understanding marijuana. New York: Oxford University Press.
   Google Scholar
• Earleywine M, Bolles JR. 2014. Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation. J Psychoactive Drugs. 46:171–177.
   PubMed Web of Science ®Google Scholar
• Grinspoon L, Bakalar JB. 1997. Marihuana, the forbidden medicine. Revised and expanded edition. New Haven: Yale Univ Press; p. 135–138.
   Google Scholar
• Haj-Dahmane S, Shen RY. 2014. Chronic stress impairs α1-adrenoceptor-induced endocannabinoid-dependent synaptic plasticity in the dorsal raphe nucleus. J Neurosci. 34:14560–14570.
   PubMed Web of Science ®Google Scholar
• Halbreich U. 2008. Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough. CNS Spectr. 13:566–572.
   PubMed Web of Science ®Google Scholar
• Hayaki J, Hagerty CE, Herman DS, de Dios MA, Anderson BJ, Stein MD. 2010. Expectancies and marijuana use frequency and severity among young females. Addict Behav. 35:995–1000.
   PubMed Web of Science ®Google Scholar
• Hayaki J, Herman DS, Hagerty CE, de Dios MA, Anderson BJ, Stein MD. 2011. Expectancies and self-efficacy mediate the effects of impulsivity on marijuana use outcomes: an application of the acquired preparedness model. Addict Behav. 36:389–396.
   PubMed Web of Science ®Google Scholar
• Ilgen MA, Bohnert K, Kleinberg F, Jannausch M, Bohnert ASB, Walton M, Blow FC. 2013. Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend. 132:654–659.
   PubMed Web of Science ®Google Scholar
• Kirk JM, Doty P, De Wit H. 1998. Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 59:287–293.
   PubMed Web of Science ®Google Scholar
• Metrik J, Rohsenow DJ, Monti PM, McGeary J, Cook TAR, de Wit H, Haney M, Kahler CW. 2009. Effectiveness of a marijuana expectancy manipulation: piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol. 17:217–225.
   PubMed Web of Science ®Google Scholar
• Osborne JW. 2013. Best practices in data cleaning. Thousand Oaks (CA): Sage.
   Google Scholar
• Panay N. 2011. Management of premenstrual syndrome: evidence-based guidelines. Obstet Gynaecol Reproduct Med. 21:221–228.
   Google Scholar
• Pearson MR, Bravo AJ, Conner BT. 2017. Distinguishing subpopulations of marijuana users with latent profile analysis. Drug Alcohol Depend. 172:1–8.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick, ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. J Am Med Assoc. 288:321–333.
   PubMed Web of Science ®Google Scholar
• Russo E. 2002. Cannabis treatments in obstetrics and gynecology: a historical review. J Cannabis Therapeutics. 2:5–35.
   Google Scholar
• Russo EB, Guy GW, Robson PJ. 2007. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of sativex??, a cannabis-based medicine. Chem Biodiversity. 4:1729–1743.
   PubMed Web of Science ®Google Scholar
• Russo EB, Hohmann AG. 2013. Role of cannabinoids in pain management. In: Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches. New York: Springer; p. 181–197.
   Google Scholar
• Schafer J, Brown SA. 1991. Marijuana and cocaine effect expectancies and drug use patterns. J Consult Clin Psychol. 59:558–565.
   PubMed Web of Science ®Google Scholar
• Segebladh B, Borgstrom A, Odlind V, Bixo M, Sundstrom-Poromaa I. 2009. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 79:50–55.
   PubMed Web of Science ®Google Scholar
• Skenderian JJ, Siegel JT, Crano WD, Alvaro EE, Lac A. 2008. Expectancy change and adolescents’ intentions to use marijuana. Psychol Addict Behav. 22:563–569.
   PubMed Web of Science ®Google Scholar
• Slavin MN, Farmer S, Earleywine M. 2016. Expectancy mediated effects of marijuana on menopause symptoms. Addict Res Theory. 24:322–329.
   Web of Science ®Google Scholar
• Stephens RS, Roffman RA, Curtin L. 2000. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol. 68:898–908.
   PubMed Web of Science ®Google Scholar
• Vangsness L, Bry BH, LaBouvie EW. 2001. Impulsivity, negative expectancies, and marijuana use: a test of the acquired preparedness model. Addict Behav. 26:1071–1076.
   Google Scholar
• Wakil L, Meltzer-Brody S, Girdler S. 2012. Premenstrual dysphoric disorder: how to alleviate her suffering. Current Psychiatry. 11:22–41. Retrieved from ttp://www.oncologypractice.com/view-pdf.html?file=fileadmin/cp_archive/pdf/1104/1104CP_Meltzer-Brody
   Google Scholar
• Wilcox RR. 2013. New statistical procedures for the social sciences: modern solutions to basic problems. Florence, KY: Psychology Press.
   Google Scholar
• Wyatt KM, Dimmock PW, Ismail KMK, Jones PW, O’Brien PMS. 2004. The effectiveness of GnRHa with and without “add-back” therapy in treating premenstrual syndrome: a meta analysis. BJOG. 111:585–593.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, O’Brien PMS, Eriksson E. 2008. Premenstrual syndrome. Lancet. 371:1200–1210.
   PubMed Web of Science ®Google Scholar